Artiva Biotherapeutics (ARTV) Rockets 116% in One Day
Artiva Biotherapeutics Inc. (NASDAQ:ARTV) is a clinical-stage biotechnology company pioneering the development of off-the-shelf, allogeneic natural killer (NK)…
Addex Therapeutics (ADXN) Targets $330 Million Milestone Payouts
Addex Therapeutics Ltd (NASDAQ:ADXN) is a clinical-stage biopharmaceutical company headquartered in Geneva, Switzerland, focused on discovering and developing innovative…
Arcadia Biosciences (RKDA) Surges 53%, But EBITDA Is Still -$5.9 Million
Arcadia Biosciences Inc. (NASDAQ:RKDA) is an agricultural biotechnology company founded in 2002 with the mission of developing innovative,…
Bright Minds Biosciences (DRUG) Surges 158.8% in 12 Weeks
Bright Minds Biosciences Inc. (NASDAQ:DRUG) is a biotechnology company focused on developing next-generation therapeutics for neurological and psychiatric disorders…
Vanda Pharmaceuticals (VNDA) Targets 300% Upside with Breakthrough FDA Framework Deal
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) is a biopharmaceutical company focused on the development and commercialization of innovative therapies that…
Delcath (DCTH) Revenue Surges with 87% Gross Margin and Zero Debt Balance Sheet
Delcath Systems Inc. (NASDAQ:DCTH) is a specialty pharmaceutical and medical device company focused on developing and commercializing innovative therapies…
ResMed (RMD) Dominates $39.7 Billion Sleep Health Market
ResMed Inc. (NYSE:RMD) is a global leader in digital health and cloud-connected medical devices, specializing in innovative solutions…
BioMarin (BMRN)’s Rare Disease Portfolio Generates Over $2.4 Billion in Annual Revenue
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is a pioneering biotechnology company specializing in the development and commercialization of therapies for…
Edwards Lifesciences (EW) Set to Report $1.50B in Q3 Sales
Edwards Lifesciences Corporation (NYSE:EW) is a global medical technology leader dedicated to the advancement of patient-focused innovations in structural…
NewAmsterdam Pharma (NAMS) Soars 93.9% in 12 Months
NewAmsterdam Pharma Co. N.V. (NASDAQ:NAMS) is a late-stage biopharmaceutical company dedicated to transforming the treatment of cardiovascular and…
Teva Pharma (TEVA) Wins FDA Approval for UZEDY’s Bipolar I Expansion
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is one of the world’s largest and most established pharmaceutical companies, headquartered in…
Radiopharm Theranostics (RADX) Halts Trading Ahead of Major Capital Raise
Radiopharm Theranostics Limited (NASDAQ:RADX) is an Australian-based clinical-stage biotechnology company pioneering advancements in radiopharmaceuticals for both diagnostic imaging…
Candel Therapeutics (CADL) Boosts Cash to $217M, Prepares for 2026 Prostate Cancer Launch
Candel Therapeutics, Inc. (NASDAQ:CADL) is a clinical-stage biopharmaceutical company pioneering the next generation of cancer immunotherapies by harnessing…
Teladoc (TDOC)’s AI Upgrade Could Be Its Biggest Breakthrough Since Livongo
Teladoc Health Inc. (NYSE:TDOC) is a global leader in virtual healthcare and telemedicine, widely recognized as the company…
Tonix Pharmaceuticals (TNXP) Plunges 20% After FDA Win
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) is a clinical-stage biopharmaceutical company headquartered in Chatham, New Jersey, dedicated to discovering,…
AstraZeneca (AZN) Targets $80 Billion Revenue by 2030
AstraZeneca PLC (NASDAQ:AZN) is one of the world’s largest and most influential biopharmaceutical companies, built on a legacy…
Akero Therapeutics (AKRO) Soars 16.52% After Liver Drug Breakthrough Shocks Wall Street
Akero Therapeutics, Inc. (NASDAQ:AKRO) is a clinical-stage biotechnology company headquartered in South San Francisco, California, focused on developing…
Molina Healthcare (MOH) Crashes 39% in a Year
Molina Healthcare Inc. (NYSE:MOH) is a leading managed care company in the United States that provides health insurance…